← back to search

Sophia Hober

KTH Royal Institute of Technology · SE
Area of research
Radiology, Nuclear Medicine and Imaging · Molecular Biology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, SARS-CoV-2 and COVID-19 Research, and Glycosylation and Glycoproteins Research.
h-index
47
citations
35,175
works
270
NIH funding
primary concept
Chemistry
email

Recent publications

Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
Nature Communications 2024cited by 42position: middledoi
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden
The Lancet Infectious Diseases 2024cited by 32position: middledoi
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
The Lancet Infectious Diseases 2023cited by 79position: middledoi
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Nature Communications 2023cited by 34position: middledoi
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
The Lancet Microbe 2023cited by 34position: middledoi
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
New England Journal of Medicine 2022cited by 252position: middledoi
Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins
Metabolic Engineering 2022cited by 43position: middledoi
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
PLoS ONE 2022cited by 43position: middledoi
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
The Lancet Infectious Diseases 2022cited by 42position: middledoi
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers
JAMA 2021cited by 416position: middledoi
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
EBioMedicine 2021cited by 223position: middledoi
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
Journal of Internal Medicine 2021cited by 71position: middledoi
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
The Journal of Infectious Diseases 2021cited by 52position: middledoi
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
EBioMedicine 2021cited by 50position: middledoi
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
iScience 2021cited by 38position: middledoi
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Nature Communications 2020cited by 327position: middledoi
The human secretome
Science Signaling 2019cited by 508position: middledoi
Enhanced validation of antibodies for research applications
Nature Communications 2018cited by 111position: middledoi
A subcellular map of the human proteome
Science 2017cited by 2,966position: middledoi
Next generation of labeling reagents for quantitative and multiplexing immunoassays by the use of LA-ICP-MS
The Analyst 2016cited by 24position: middledoi
Tissue-based map of the human proteome
Science 2015cited by 15,767position: middledoi
Developments in biobanking workflow standardization providing sample integrity and stability
Journal of Proteomics 2013cited by 59position: middledoi
Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP)
Journal of Proteome Research 2012cited by 50position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sebastian Havervall · Karolinska Institutet11 papers (2020–2024)Charlotte Thålin · Karolinska Institutet11 papers (2020–2024)Peter Nilsson · Science for Life Laboratory10 papers (2020–2024)Nina Greilert‐Norin · Karolinska Institutet8 papers (2021–2024)Jonas Klingström · Linköping University8 papers (2021–2024)Mikael Åberg · Uppsala University7 papers (2021–2024)Kim Blom · Swedish Armed Forces7 papers (2021–2024)Ulrika Marking · Swedish Armed Forces7 papers (2021–2024)Max Gordon · North Carolina State University6 papers (2021–2023)Mia Phillipson · Science for Life Laboratory6 papers (2020–2023)Elisa Pin · Science for Life Laboratory6 papers (2020–2024)Hanna Tegel · KTH Royal Institute of Technology5 papers (2018–2024)Sara M. Mangsbo · Uppsala University5 papers (2021–2023)Anna Månberg · Science for Life Laboratory5 papers (2020–2024)Anna Smed‐Sörensen · Karolinska University Hospital4 papers (2022–2023)Henry Ng · Karolinska Institutet4 papers (2020–2023)Katherina Aguilera · Glanrhyd Hospital4 papers (2020–2024)Cecilia Hellström · Science for Life Laboratory4 papers (2020–2022)Oscar Bladh · Karolinska Institutet4 papers (2023–2024)August Jernbom Falk · Science for Life Laboratory3 papers (2020–2024)